BLISSGVS.NS
Bliss GVS Pharma Limited
NSEINREQUITY
Healthcare
DELAYED
Last price
579.10
▼ 1.05 (0.18%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
582.00
Prev close
580.15
Day high
593.00
Day low
560.00
Volume
206.32K
Market cap
$61.54B
P/E (TTM)
45.89
52W range
118.00 – 602.45
Day trading desk
Gap from prior close
+0.32%
Prior close 580.15
VWAP
574.98
+0.72% from price
Relative volume
0.15×
Quiet session
Session range
5.89%
560.00 – 593.00
Position in range
58%
Mid range
ATR (14D)
29.18
5.04% of price
Prior day high
602.45
PDH
Prior day low
572.00
PDL
Bid / ask spread
—
Quote not published
Session volume
209.59K
Avg 1.42M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+11.53%
+12.9%
1M
+25.39%
+21.7%
3M
+51.97%
+48.9%
6M
+155.71%
+144.6%
YTD
+254.43%
+242.1%
1Y
+232.87%
+212.9%
3Y
+537.42%
+463.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on BLISSGVS.NS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
60.81M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Dec 16, 25 | Sharma (Gagan Harsh) Promoter |
BUY | 2.12K | $3.29K | Direct |
| Dec 15, 25 | Sharma (Gagan Harsh) Promoter |
BUY | 5.00K | $7.83K | Direct |
| Dec 12, 25 | Sharma (Gagan Harsh) Promoter |
BUY | 10.00K | $15.91K | Direct |
| Jun 27, 25 | Sharma (Gagan Harsh) Promoter |
BUY | 2.67K | $4.93K | Direct |
| Jun 26, 25 | Sharma (Gagan Harsh) Promoter |
BUY | 24.82K | $43.08K | Direct |
| Jun 25, 25 | Sharma (Gagan Harsh) Promoter |
BUY | 7.50K | $12.97K | Direct |
| Jun 24, 25 | Sharma (Gagan Harsh) Promoter |
BUY | 26.06K | $45.27K | Direct |
| Jun 23, 25 | Sharma (Gagan Harsh) Promoter |
BUY | 6.76K | $10.80K | Direct |
| Jun 10, 25 | Sharma (Gagan Harsh) Promoter |
BUY | 1.97K | $3.15K | Direct |
| Jun 9, 25 | Sharma (Gagan Harsh) Promoter |
BUY | 46.66K | $74.46K | Direct |
| May 22, 25 | Sharma (Gagan Harsh) Promoter |
BUY | 4.71K | $6.65K | Direct |
| May 21, 25 | Sharma (Gagan Harsh) Promoter |
BUY | 37.26K | $52.76K | Direct |
| May 20, 25 | Sharma (Gagan Harsh) Promoter |
BUY | 41.60K | $59.09K | Direct |
| Mar 21, 25 | Sharma (Vibha Gagan) Promoter |
BUY | 25.00K | $35.65K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Kamath (Shibroor Narasimha) |
Promoter | 32.44M | Acquisition |
Sharma (Gagan Harsh) |
Promoter | 217.12K | Acquisition |
Sharma (Vibha Gagan) |
Promoter | 2.58M | Acquisition |
Fundamentals
Market cap$61.54B
Enterprise value$59.98B
Revenue (TTM)$10.05B
Gross profit$5.35B
EBITDA$1.92B
Net income$1.36B
EPS (TTM)$12.62
Free cash flow—
Total cash$1.89B
Total debt$217.50M
Book value / share$112.76
Shares outstanding106.28M
Float45.10M
Short % of float—
Dividend yield0.35%
Beta (5Y)1.19
Valuation & profitability ratios
Trailing P/E45.89
Forward P/E—
PEG ratio—
Price / sales—
Price / book5.14
EV / revenue5.97
EV / EBITDA31.21
Gross margin53.21%
Operating margin23.27%
Profit margin13.55%
Return on equity—
Return on assets—
Debt / equity1.77
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $9.21B | $8.02B | $7.66B | $7.47B | +14.8% |
| Operating revenue | $9.21B | $8.02B | $7.66B | $7.47B | +14.8% |
| Cost of revenue | $4.25B | $4.14B | $3.82B | $4.01B | +2.7% |
| Gross profit | $4.96B | $3.88B | $3.84B | $3.46B | +27.7% |
| Research & development | $550.27M | $293.00M | $337.25M | $217.89M | +87.8% |
| Selling, general & admin | $547.14M | $555.30M | $430.88M | $494.42M | -1.5% |
| Total operating expense | $3.36B | $2.90B | $2.49B | $2.45B | +15.9% |
| Operating income | $1.59B | $977.58M | $1.35B | $1.01B | +62.7% |
| Net interest income | $120.62M | $87.58M | $53.67M | $37.59M | +37.7% |
| Pre-tax income | $1.90B | $1.26B | $1.17B | $1.06B | +50.9% |
| Tax provision | $548.62M | $353.84M | $352.94M | $293.37M | +55.0% |
| Net income | $1.29B | $842.99M | $754.54M | $708.59M | +53.2% |
| Net income to common | $1.29B | $842.99M | $754.54M | $708.59M | +53.2% |
| Basic EPS | 12.23 | 8.02 | 7.23 | 6.83 | +52.5% |
| Diluted EPS | 12.00 | 7.95 | 7.11 | 6.72 | +50.9% |
| EBIT | $1.93B | $1.32B | $1.22B | $1.09B | +46.6% |
| EBITDA | $2.27B | $1.61B | $1.49B | $1.28B | +40.7% |
| Basic shares | 105.62M | 105.11M | 104.31M | 103.81M | +0.5% |
| Diluted shares | 107.60M | 106.03M | 106.07M | 105.48M | +1.5% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $351.42M | $237.94M | $231.40M | $249.55M | +47.7% |
| Cash & short-term investments | $1.89B | $1.41B | $1.41B | $684.11M | +33.8% |
| Accounts receivable | $5.17B | $4.39B | $4.04B | $3.85B | +17.9% |
| Inventory | $1.51B | $1.26B | $1.18B | $1.03B | +19.9% |
| Total current assets | $9.46B | $8.24B | $8.11B | $6.97B | +14.9% |
| Property, plant & equipment | $4.60B | $4.30B | $3.80B | $3.89B | +7.1% |
| Goodwill & intangibles | $79.25M | $79.41M | $78.18M | $79.41M | -0.2% |
| Total assets | $14.92B | $13.01B | $12.12B | $11.57B | +14.7% |
| Total current liabilities | $2.36B | $1.72B | $1.57B | $1.93B | +36.8% |
| Current debt | $29.26M | $511.29M | $522.14M | $573.77M | -94.3% |
| Long-term debt | $0 | $198.46M | $355.92M | $406.90M | -100.0% |
| Total debt | $217.50M | $881.04M | $998.40M | $1.02B | -75.3% |
| Total liabilities | $2.61B | $2.09B | $2.09B | $2.39B | +24.5% |
| Retained earnings | $10.86B | $9.67B | $8.87B | $8.15B | +12.3% |
| Shareholder equity | $11.93B | $10.50B | $9.67B | $8.84B | +13.6% |
| Working capital | $7.11B | $6.52B | $6.53B | $5.04B | +9.1% |
| Net tangible assets | $11.85B | $10.42B | $9.59B | $8.76B | +13.7% |
| Shares issued | 105.79M | 105.37M | 104.69M | 104.15M | +0.4% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $1.90B | $1.26B | $1.46B | $1.06B | +50.9% |
| Depreciation & amortisation | $334.83M | $294.18M | $263.80M | $186.73M | +13.8% |
| Stock-based compensation | $86.24M | $41.40M | $38.16M | $39.04M | +108.3% |
| Change in working capital | -$1.04B | -$514.56M | -$465.71M | -$851.19M | -103.0% |
| Operating cash flow | $1.39B | $1.06B | $1.03B | $343.13M | +31.0% |
| Capital expenditure | -$568.31M | -$762.86M | -$283.29M | -$937.99M | +25.5% |
| Investing cash flow | -$382.80M | -$755.87M | -$831.90M | -$77.51M | +49.4% |
| Dividends paid | -$106.36M | -$53.95M | -$53.95M | -$54.37M | -97.2% |
| Financing cash flow | -$892.11M | -$301.98M | -$208.93M | -$249.38M | -195.4% |
| Free cash flow | $818.87M | $296.27M | $744.87M | -$594.86M | +176.4% |
| End cash position | $351.42M | $238.17M | $235.91M | $250.07M | +47.6% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $2.57B | $2.18B | $2.44B | $2.07B | $1.98B | +17.8% |
| Operating revenue | $2.57B | $2.18B | $2.44B | $2.07B | $1.98B | +17.8% |
| Cost of revenue | $1.13B | $1.02B | $1.18B | $918.91M | $994.28M | +11.6% |
| Gross profit | $1.44B | $1.17B | $1.26B | $1.16B | $985.58M | +23.1% |
| Total operating expense | $1.08B | $901.49M | $1.03B | $824.49M | $855.08M | +19.5% |
| Operating income | $357.69M | $264.39M | $234.97M | $331.28M | $130.50M | +35.3% |
| Net interest income | -$20.07M | -$14.86M | -$30.42M | -$54.72M | -$16.78M | -35.1% |
| Pre-tax income | $449.49M | $408.96M | $406.33M | $631.11M | $234.41M | +9.9% |
| Tax provision | $79.51M | $161.17M | $120.44M | $187.50M | $67.88M | -50.7% |
| Net income | $355.75M | $232.66M | $272.50M | $430.38M | $155.39M | +52.9% |
| Net income to common | $355.75M | $232.66M | $272.50M | $430.38M | $155.39M | +52.9% |
| Basic EPS | 3.27 | 2.20 | 2.58 | 4.08 | 1.47 | +48.6% |
| Diluted EPS | 3.27 | 2.14 | 2.54 | 4.04 | 1.46 | +52.8% |
| EBIT | $469.56M | $423.82M | $436.75M | $685.82M | $251.18M | +10.8% |
| EBITDA | $556.27M | $507.31M | $519.36M | $767.84M | $331.55M | +9.7% |
| Basic shares | 108.79M | 105.75M | 105.62M | 105.49M | 105.71M | +2.9% |
| Diluted shares | 108.79M | 108.72M | 107.29M | 106.53M | 106.43M | +0.1% |
| Line item | 2026-03-31 | 2025-09-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $351.42M | $291.47M | $237.94M | +20.6% |
| Cash & short-term investments | $1.89B | $2.46B | $1.41B | -23.1% |
| Accounts receivable | $5.17B | $4.91B | $4.39B | +5.3% |
| Inventory | $1.51B | $1.19B | $1.26B | +26.7% |
| Total current assets | $9.46B | $8.90B | $8.24B | +6.3% |
| Property, plant & equipment | $4.60B | $4.23B | $4.30B | +8.8% |
| Goodwill & intangibles | $79.25M | $79.39M | $79.41M | -0.2% |
| Total assets | $14.92B | $14.00B | $13.01B | +6.6% |
| Total current liabilities | $2.36B | $2.00B | $1.72B | +18.0% |
| Current debt | $29.26M | $229.54M | $511.29M | -87.3% |
| Long-term debt | $0 | $130.41M | $198.46M | -100.0% |
| Total debt | $217.50M | $524.91M | $881.04M | -58.6% |
| Total liabilities | $2.61B | $2.32B | $2.09B | +12.4% |
| Retained earnings | $10.86B | — | $9.67B | — |
| Shareholder equity | $11.93B | $11.32B | $10.50B | +5.3% |
| Working capital | $7.11B | $6.90B | $6.52B | +2.9% |
| Net tangible assets | $11.85B | $11.24B | $10.42B | +5.4% |
| Shares issued | 105.79M | 105.65M | 105.37M | +0.1% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Sep 2019 | 3.90 | 3.00 | -23.1% |
| Jun 2019 | — | 3.28 | — |
| Mar 2019 | 2.89 | 1.76 | -39.1% |
| Dec 2018 | 3.75 | 2.50 | -33.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders57.48%
Held by institutions9.82%
Institutions holding11
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
529.67
+9.33% from price
SMA 20
500.37
+15.73% from price
SMA 50
495.86
+16.79% from price
SMA 100
404.15
+43.29% from price
SMA 200
293.13
+97.55% from price
EMA 12
533.22
+8.60% from price
EMA 26
509.23
+13.72% from price
EMA 50
479.80
+20.70% from price
RSI (14)
75.9
Overbought
MACD (12,26,9)
23.99
Hist 10.33
ATR (14)
29.18
5.04% of price
Realised vol 30D
40.1%
Annualised
Bollinger upper
581.46
20, 2σ
Bollinger lower
419.28
20, 2σ
50 / 200 cross
Golden
495.86 vs 293.13
Trend bias
Above 200
+97.55%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.11
Less volatile than market
Correlation to SPY
-0.02
Largely independent
Realised vol 30D
40.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-23.1%
Peak to trough
Max drawdown 5Y
-40.9%
Peak to trough
ATR 14
29.18
5.04% of price
Beta (reported)
1.19
5Y monthly, from filing
Dividends & splits
Forward rate$2.00 / yr
Forward yield0.35%
5-year avg yield0.47%
Payout ratio7.93%
Ex-dividend dateJul 8, 2026
Next pay date—
Last split8:5
Split dateSep 26, 2008
Headlines
Should You Take Profits on XRP After a 50% Week? We Asked 2 AI Models
24/7 Wall St. · 10m ago
Gas Turbine Prices Are on Track to Nearly Triple. These Stocks Are Cashing In
Motley Fool · 14m ago
Loudoun County raked in $1.1 billion in tax revenue from data centers — then residents started pushing back
Moneywise · 15m ago
America’s Fastest Growing Retirement Town Is Not in Florida or Arizona
24/7 Wall St. · 15m ago
Dropbox's CFO Filed Days After Raising Guidance. What Should Investors Make of the Sequence?
Motley Fool · 18m ago
Greg Abel Just Spent $23.5 Billion on 9 Stocks for Berkshire Hathaway. Here's the Best of the Bunch.
Motley Fool · 25m ago
The $1.7 Trillion Job Apocalypse: Why Investors Can’t Ignore Humanoid Robots
24/7 Wall St. · 27m ago
Dropbox's CTO Is Selling on a Plan He Set 15 Months Ago. Here's What to Know
Motley Fool · 27m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.